Voorheis steps down at Advanced NMR

Article

William Voorheis of Advanced NMR has become the latest chief executive to leave a medical imagingcompany after posting 1994 annual results. Advanced NMR announcedthis month that Voorheis is vacating his positions as presidentand COO of the Wilmington,

William Voorheis of Advanced NMR has become the latest chief executive to leave a medical imagingcompany after posting 1994 annual results. Advanced NMR announcedthis month that Voorheis is vacating his positions as presidentand COO of the Wilmington, MA, firm. He will continue to workwith the company in a consulting capacity and remains a directorof Advanced NMR and its subsidiary, Advanced Mammography Systems.

The announcement came 10 days after Advanced NMR posted 1994numbers that saw its revenues increase 173% and its net loss drop42% (SCAN 4/12/95). Voorheis is the third medical imaging executivein the past two months to have lost his job within weeks of releasing1994 results, following Alan Margulis of MMI Medical and DavidRose of OEC Medical Systems (SCAN 3/29/95 and 3/1/95).

An Advanced NMR spokesperson said Voorheis had done an "excellent"job at the firm, but the company felt it needed new blood to moveon to the next level of sales and production. Advanced NMR marketsthe InstaScan echo-planar imaging package and its Advanced MammographySystems subsidiary is developing the Aurora dedicated MR mammographyscanner.

Advanced NMR chairman and CEO Jack Nelson has been appointedacting president of both Advanced NMR and Advanced MammographySystems. Vice president of sales and marketing Robert Kwolyk hasassumed Voorheis' COO duties.

In other Advanced NMR news, the company said that in conjunctionwith Advanced Mammography Systems it has developed a new MR mammographyfat-suppression technique to distinguish tumor from normal fattybreast tissue. The method reduces breast imaging times to undersix minutes, according to the company.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.